Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janelle Sharkey

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer Research|April 17, 2008
Interleukin 21 enhances antibody-mediated tumor rejectionMark J Smyth, Michele W L Teng, Janelle Sharkey, et al.
Cancer Research|March 25, 2010
Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletionMichele W L Teng, Jeremy B Swann, Bianca von Scheidt, et al.
Plos One|September 4, 2015
Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b GeneCarmen S M Yong, Janelle Sharkey, Belinda Duscio, et al.
Cancer Research|August 3, 2007
Combined natural killer T-cell based immunotherapy eradicates established tumors in miceMichele W L Teng, Jennifer A Westwood, Phillip K Darcy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2008
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonistAilsa J Frew, Ralph K Lindemann, Ben P Martin, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer Research|April 17, 2008
Interleukin 21 enhances antibody-mediated tumor rejectionMark J Smyth, Michele W L Teng, Janelle Sharkey, et al.
Cancer Research|March 25, 2010
Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletionMichele W L Teng, Jeremy B Swann, Bianca von Scheidt, et al.
Plos One|September 4, 2015
Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b GeneCarmen S M Yong, Janelle Sharkey, Belinda Duscio, et al.
Cancer Research|August 3, 2007
Combined natural killer T-cell based immunotherapy eradicates established tumors in miceMichele W L Teng, Jennifer A Westwood, Phillip K Darcy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2008
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonistAilsa J Frew, Ralph K Lindemann, Ben P Martin, et al.
Pageof 2